Govt Must Move Fast On Next Generation Covid-19 Treatments

Published: Tue 25 Jan 2022 02:44 PM
The Government must move as fast as possible to approve and order supply of promising new Covid-19 treatments, National’s Covid-19 Response spokesperson Chris Bishop says.
“Lagevrio (molnupiravir) and Paxlovid have both been approved by the Therapeutic Goods Administration in Australia, and regulatory bodies in the United Kingdom and the United States, but we are on the go-slow here in New Zealand.
“With Omicron now in our community and with cases likely to increase quickly, we need access to these next generation Covid-19 treatments fast.
“Paxlovid in particular is very exciting. Initial results show it significantly reduces (by 89%) hospital admissions and deaths among people with Covid-19 who are at high risk of severe illness.
“New Zealand has purchased 60,000 courses but it is not approved here yet and supply won’t arrive until April.
“We will be well into the Omicron outbreak by April and we need the option of these treatments as soon as possible.
“National’s pressure led the Government to sign advance purchase agreements for both Lagevrio (molnupiravir) and Paxlovid last year. The Government did the right thing by establishing a dedicated fund inside Pharmac to purchase these treatments in advance of them being approved, which National suggested in September.
“Now the Government needs to make sure we have supply of these treatments as soon as possible and that approval is expedited.”

Next in New Zealand politics

PM’s Chatham House Speech
By: New Zealand Government
New Zealand Secures Major Free Trade Deal With European Union
By: New Zealand Government
New Measures To Help Manage COVID-19 As Country Stays At Orange
By: New Zealand Government
New Era For Better Health In Aotearoa New Zealand
By: New Zealand Government
Alcohol Harm Minimisation Bill Pulled From Biscuit Tin
By: Green Party
Wellington’s Rapid Transit Option Progresses To Next Stage
By: New Zealand Government
EU Market Remains Largely Closed To NZ Dairy
By: Dairy Companies Association of New Zealand
Winners And Losers In NZ-EU FTA
By: Business NZ
View as: DESKTOP | MOBILE © Scoop Media